nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—NISCH—Paclitaxel—Docetaxel—ovarian cancer	0.0112	0.446	CbGdCrCtD
Tizanidine—NISCH—uterine cervix—ovarian cancer	0.00789	0.0798	CbGeAlD
Tizanidine—NISCH—Vincristine—Vinorelbine—ovarian cancer	0.00773	0.307	CbGdCrCtD
Tizanidine—NISCH—decidua—ovarian cancer	0.00752	0.076	CbGeAlD
Tizanidine—NISCH—uterus—ovarian cancer	0.00658	0.0665	CbGeAlD
Tizanidine—NISCH—Vinblastine—Vinorelbine—ovarian cancer	0.00622	0.247	CbGdCrCtD
Tizanidine—NISCH—bone marrow—ovarian cancer	0.00558	0.0564	CbGeAlD
Tizanidine—NISCH—female gonad—ovarian cancer	0.00538	0.0544	CbGeAlD
Tizanidine—NISCH—vagina—ovarian cancer	0.00535	0.0541	CbGeAlD
Tizanidine—NISCH—testis—ovarian cancer	0.00477	0.0482	CbGeAlD
Tizanidine—ADRA2C—myometrium—ovarian cancer	0.00463	0.0468	CbGeAlD
Tizanidine—ADRA2A—myometrium—ovarian cancer	0.0037	0.0374	CbGeAlD
Tizanidine—ADRA2C—uterine cervix—ovarian cancer	0.00361	0.0364	CbGeAlD
Tizanidine—NISCH—lymph node—ovarian cancer	0.00346	0.035	CbGeAlD
Tizanidine—ADRA2C—decidua—ovarian cancer	0.00343	0.0347	CbGeAlD
Tizanidine—ADRA2C—endometrium—ovarian cancer	0.00326	0.033	CbGeAlD
Tizanidine—ADRA2C—uterus—ovarian cancer	0.003	0.0304	CbGeAlD
Tizanidine—ADRA2A—uterine cervix—ovarian cancer	0.00288	0.0291	CbGeAlD
Tizanidine—ADRA2A—decidua—ovarian cancer	0.00274	0.0277	CbGeAlD
Tizanidine—ADRA2A—endometrium—ovarian cancer	0.0026	0.0263	CbGeAlD
Tizanidine—ADRA2C—female gonad—ovarian cancer	0.00246	0.0248	CbGeAlD
Tizanidine—ADRA2C—vagina—ovarian cancer	0.00244	0.0247	CbGeAlD
Tizanidine—ADRA2A—gonad—ovarian cancer	0.00241	0.0244	CbGeAlD
Tizanidine—ADRA2A—uterus—ovarian cancer	0.0024	0.0242	CbGeAlD
Tizanidine—ADRA2C—testis—ovarian cancer	0.00218	0.022	CbGeAlD
Tizanidine—ADRA2A—female reproductive system—ovarian cancer	0.00216	0.0218	CbGeAlD
Tizanidine—ADRA2A—female gonad—ovarian cancer	0.00196	0.0198	CbGeAlD
Tizanidine—ADRA2A—vagina—ovarian cancer	0.00195	0.0197	CbGeAlD
Tizanidine—ADRA2A—testis—ovarian cancer	0.00174	0.0176	CbGeAlD
Tizanidine—ADRA2C—lymph node—ovarian cancer	0.00158	0.016	CbGeAlD
Tizanidine—ADRA2A—lymph node—ovarian cancer	0.00126	0.0127	CbGeAlD
Tizanidine—Angina pectoris—Epirubicin—ovarian cancer	0.000649	0.000741	CcSEcCtD
Tizanidine—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000649	0.00074	CcSEcCtD
Tizanidine—Tachycardia—Paclitaxel—ovarian cancer	0.000647	0.000738	CcSEcCtD
Tizanidine—Skin disorder—Paclitaxel—ovarian cancer	0.000643	0.000735	CcSEcCtD
Tizanidine—Bronchitis—Epirubicin—ovarian cancer	0.00064	0.000731	CcSEcCtD
Tizanidine—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00064	0.000731	CcSEcCtD
Tizanidine—Anaemia—Docetaxel—ovarian cancer	0.000636	0.000726	CcSEcCtD
Tizanidine—Muscular weakness—Doxorubicin—ovarian cancer	0.000629	0.000718	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000629	0.000718	CcSEcCtD
Tizanidine—Vomiting—Vinorelbine—ovarian cancer	0.000626	0.000715	CcSEcCtD
Tizanidine—Rash—Vinorelbine—ovarian cancer	0.000621	0.000709	CcSEcCtD
Tizanidine—Dermatitis—Vinorelbine—ovarian cancer	0.00062	0.000708	CcSEcCtD
Tizanidine—Hypotension—Paclitaxel—ovarian cancer	0.000619	0.000707	CcSEcCtD
Tizanidine—Syncope—Docetaxel—ovarian cancer	0.000617	0.000704	CcSEcCtD
Tizanidine—Influenza—Doxorubicin—ovarian cancer	0.000616	0.000704	CcSEcCtD
Tizanidine—Dysphagia—Doxorubicin—ovarian cancer	0.000616	0.000704	CcSEcCtD
Tizanidine—Asthma—Doxorubicin—ovarian cancer	0.000616	0.000704	CcSEcCtD
Tizanidine—Leukopenia—Docetaxel—ovarian cancer	0.000616	0.000703	CcSEcCtD
Tizanidine—Pollakiuria—Epirubicin—ovarian cancer	0.000615	0.000702	CcSEcCtD
Tizanidine—Loss of consciousness—Docetaxel—ovarian cancer	0.000605	0.00069	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000604	0.000689	CcSEcCtD
Tizanidine—Weight decreased—Epirubicin—ovarian cancer	0.000603	0.000688	CcSEcCtD
Tizanidine—Hyperglycaemia—Epirubicin—ovarian cancer	0.000601	0.000686	CcSEcCtD
Tizanidine—Angina pectoris—Doxorubicin—ovarian cancer	0.0006	0.000685	CcSEcCtD
Tizanidine—Pneumonia—Epirubicin—ovarian cancer	0.000597	0.000682	CcSEcCtD
Tizanidine—Convulsion—Docetaxel—ovarian cancer	0.000596	0.000681	CcSEcCtD
Tizanidine—Paraesthesia—Paclitaxel—ovarian cancer	0.000595	0.000679	CcSEcCtD
Tizanidine—Hypertension—Docetaxel—ovarian cancer	0.000594	0.000678	CcSEcCtD
Tizanidine—Drowsiness—Epirubicin—ovarian cancer	0.000594	0.000678	CcSEcCtD
Tizanidine—Bronchitis—Doxorubicin—ovarian cancer	0.000593	0.000677	CcSEcCtD
Tizanidine—Dyspnoea—Paclitaxel—ovarian cancer	0.000591	0.000674	CcSEcCtD
Tizanidine—Somnolence—Paclitaxel—ovarian cancer	0.000589	0.000672	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000589	0.000672	CcSEcCtD
Tizanidine—Arthralgia—Docetaxel—ovarian cancer	0.000586	0.000669	CcSEcCtD
Tizanidine—Nausea—Vinorelbine—ovarian cancer	0.000585	0.000668	CcSEcCtD
Tizanidine—Renal failure—Epirubicin—ovarian cancer	0.000584	0.000666	CcSEcCtD
Tizanidine—Dyspepsia—Paclitaxel—ovarian cancer	0.000583	0.000666	CcSEcCtD
Tizanidine—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000582	0.000665	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000582	0.000664	CcSEcCtD
Tizanidine—Jaundice—Epirubicin—ovarian cancer	0.000579	0.000661	CcSEcCtD
Tizanidine—Conjunctivitis—Epirubicin—ovarian cancer	0.000577	0.000659	CcSEcCtD
Tizanidine—Dry mouth—Docetaxel—ovarian cancer	0.000573	0.000654	CcSEcCtD
Tizanidine—Fatigue—Paclitaxel—ovarian cancer	0.000571	0.000652	CcSEcCtD
Tizanidine—Sweating—Epirubicin—ovarian cancer	0.000569	0.00065	CcSEcCtD
Tizanidine—Pollakiuria—Doxorubicin—ovarian cancer	0.000569	0.00065	CcSEcCtD
Tizanidine—Constipation—Paclitaxel—ovarian cancer	0.000566	0.000647	CcSEcCtD
Tizanidine—Haematuria—Epirubicin—ovarian cancer	0.000566	0.000646	CcSEcCtD
Tizanidine—Confusional state—Docetaxel—ovarian cancer	0.000566	0.000646	CcSEcCtD
Tizanidine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000562	0.000641	CcSEcCtD
Tizanidine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000561	0.000641	CcSEcCtD
Tizanidine—Oedema—Docetaxel—ovarian cancer	0.000561	0.000641	CcSEcCtD
Tizanidine—Infection—Docetaxel—ovarian cancer	0.000558	0.000637	CcSEcCtD
Tizanidine—Weight decreased—Doxorubicin—ovarian cancer	0.000557	0.000636	CcSEcCtD
Tizanidine—Sinusitis—Epirubicin—ovarian cancer	0.000557	0.000636	CcSEcCtD
Tizanidine—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000556	0.000635	CcSEcCtD
Tizanidine—Agranulocytosis—Epirubicin—ovarian cancer	0.000554	0.000633	CcSEcCtD
Tizanidine—Pneumonia—Doxorubicin—ovarian cancer	0.000553	0.000631	CcSEcCtD
Tizanidine—Shock—Docetaxel—ovarian cancer	0.000552	0.000631	CcSEcCtD
Tizanidine—Nervous system disorder—Docetaxel—ovarian cancer	0.000551	0.000629	CcSEcCtD
Tizanidine—Thrombocytopenia—Docetaxel—ovarian cancer	0.00055	0.000628	CcSEcCtD
Tizanidine—Drowsiness—Doxorubicin—ovarian cancer	0.000549	0.000627	CcSEcCtD
Tizanidine—Tachycardia—Docetaxel—ovarian cancer	0.000548	0.000626	CcSEcCtD
Tizanidine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000546	0.000623	CcSEcCtD
Tizanidine—Skin disorder—Docetaxel—ovarian cancer	0.000545	0.000623	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000545	0.000622	CcSEcCtD
Tizanidine—Bradycardia—Epirubicin—ovarian cancer	0.000543	0.00062	CcSEcCtD
Tizanidine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000542	0.000618	CcSEcCtD
Tizanidine—Renal failure—Doxorubicin—ovarian cancer	0.00054	0.000617	CcSEcCtD
Tizanidine—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000539	0.000615	CcSEcCtD
Tizanidine—Haemoglobin—Epirubicin—ovarian cancer	0.000536	0.000612	CcSEcCtD
Tizanidine—Jaundice—Doxorubicin—ovarian cancer	0.000536	0.000611	CcSEcCtD
Tizanidine—Rhinitis—Epirubicin—ovarian cancer	0.000534	0.00061	CcSEcCtD
Tizanidine—Conjunctivitis—Doxorubicin—ovarian cancer	0.000534	0.00061	CcSEcCtD
Tizanidine—Haemorrhage—Epirubicin—ovarian cancer	0.000533	0.000609	CcSEcCtD
Tizanidine—Hepatitis—Epirubicin—ovarian cancer	0.000533	0.000609	CcSEcCtD
Tizanidine—Pharyngitis—Epirubicin—ovarian cancer	0.000529	0.000604	CcSEcCtD
Tizanidine—Sweating—Doxorubicin—ovarian cancer	0.000527	0.000601	CcSEcCtD
Tizanidine—Urinary tract disorder—Epirubicin—ovarian cancer	0.000526	0.000601	CcSEcCtD
Tizanidine—Urticaria—Paclitaxel—ovarian cancer	0.000526	0.000601	CcSEcCtD
Tizanidine—Hypotension—Docetaxel—ovarian cancer	0.000525	0.000599	CcSEcCtD
Tizanidine—Haematuria—Doxorubicin—ovarian cancer	0.000524	0.000598	CcSEcCtD
Tizanidine—Connective tissue disorder—Epirubicin—ovarian cancer	0.000524	0.000598	CcSEcCtD
Tizanidine—Abdominal pain—Paclitaxel—ovarian cancer	0.000524	0.000598	CcSEcCtD
Tizanidine—Body temperature increased—Paclitaxel—ovarian cancer	0.000524	0.000598	CcSEcCtD
Tizanidine—Urethral disorder—Epirubicin—ovarian cancer	0.000523	0.000597	CcSEcCtD
Tizanidine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.00052	0.000593	CcSEcCtD
Tizanidine—Sinusitis—Doxorubicin—ovarian cancer	0.000515	0.000589	CcSEcCtD
Tizanidine—Agranulocytosis—Doxorubicin—ovarian cancer	0.000513	0.000585	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000512	0.000584	CcSEcCtD
Tizanidine—Paraesthesia—Docetaxel—ovarian cancer	0.000504	0.000576	CcSEcCtD
Tizanidine—Erythema multiforme—Epirubicin—ovarian cancer	0.000504	0.000575	CcSEcCtD
Tizanidine—Bradycardia—Doxorubicin—ovarian cancer	0.000502	0.000573	CcSEcCtD
Tizanidine—Dyspnoea—Docetaxel—ovarian cancer	0.000501	0.000572	CcSEcCtD
Tizanidine—Somnolence—Docetaxel—ovarian cancer	0.000499	0.00057	CcSEcCtD
Tizanidine—Tinnitus—Epirubicin—ovarian cancer	0.000497	0.000567	CcSEcCtD
Tizanidine—Haemoglobin—Doxorubicin—ovarian cancer	0.000496	0.000566	CcSEcCtD
Tizanidine—Cardiac disorder—Epirubicin—ovarian cancer	0.000495	0.000565	CcSEcCtD
Tizanidine—Rhinitis—Doxorubicin—ovarian cancer	0.000494	0.000565	CcSEcCtD
Tizanidine—Dyspepsia—Docetaxel—ovarian cancer	0.000494	0.000564	CcSEcCtD
Tizanidine—Haemorrhage—Doxorubicin—ovarian cancer	0.000493	0.000563	CcSEcCtD
Tizanidine—Hepatitis—Doxorubicin—ovarian cancer	0.000493	0.000563	CcSEcCtD
Tizanidine—Pharyngitis—Doxorubicin—ovarian cancer	0.00049	0.000559	CcSEcCtD
Tizanidine—Hypersensitivity—Paclitaxel—ovarian cancer	0.000488	0.000557	CcSEcCtD
Tizanidine—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000487	0.000556	CcSEcCtD
Tizanidine—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000485	0.000553	CcSEcCtD
Tizanidine—Fatigue—Docetaxel—ovarian cancer	0.000484	0.000553	CcSEcCtD
Tizanidine—Angiopathy—Epirubicin—ovarian cancer	0.000484	0.000552	CcSEcCtD
Tizanidine—Urethral disorder—Doxorubicin—ovarian cancer	0.000483	0.000552	CcSEcCtD
Tizanidine—Immune system disorder—Epirubicin—ovarian cancer	0.000481	0.00055	CcSEcCtD
Tizanidine—Mediastinal disorder—Epirubicin—ovarian cancer	0.00048	0.000548	CcSEcCtD
Tizanidine—Constipation—Docetaxel—ovarian cancer	0.00048	0.000548	CcSEcCtD
Tizanidine—Arrhythmia—Epirubicin—ovarian cancer	0.000476	0.000544	CcSEcCtD
Tizanidine—Asthenia—Paclitaxel—ovarian cancer	0.000475	0.000543	CcSEcCtD
Tizanidine—Alopecia—Epirubicin—ovarian cancer	0.000471	0.000538	CcSEcCtD
Tizanidine—Pruritus—Paclitaxel—ovarian cancer	0.000469	0.000535	CcSEcCtD
Tizanidine—Mental disorder—Epirubicin—ovarian cancer	0.000467	0.000533	CcSEcCtD
Tizanidine—Erythema multiforme—Doxorubicin—ovarian cancer	0.000466	0.000532	CcSEcCtD
Tizanidine—Feeling abnormal—Docetaxel—ovarian cancer	0.000463	0.000528	CcSEcCtD
Tizanidine—Tinnitus—Doxorubicin—ovarian cancer	0.00046	0.000525	CcSEcCtD
Tizanidine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000459	0.000524	CcSEcCtD
Tizanidine—Cardiac disorder—Doxorubicin—ovarian cancer	0.000458	0.000523	CcSEcCtD
Tizanidine—Flatulence—Epirubicin—ovarian cancer	0.000457	0.000522	CcSEcCtD
Tizanidine—Tension—Epirubicin—ovarian cancer	0.000455	0.00052	CcSEcCtD
Tizanidine—Diarrhoea—Paclitaxel—ovarian cancer	0.000453	0.000517	CcSEcCtD
Tizanidine—Nervousness—Epirubicin—ovarian cancer	0.000451	0.000515	CcSEcCtD
Tizanidine—Back pain—Epirubicin—ovarian cancer	0.000449	0.000512	CcSEcCtD
Tizanidine—Angiopathy—Doxorubicin—ovarian cancer	0.000447	0.000511	CcSEcCtD
Tizanidine—Muscle spasms—Epirubicin—ovarian cancer	0.000446	0.000509	CcSEcCtD
Tizanidine—Immune system disorder—Doxorubicin—ovarian cancer	0.000446	0.000509	CcSEcCtD
Tizanidine—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000445	0.000508	CcSEcCtD
Tizanidine—Abdominal pain—Docetaxel—ovarian cancer	0.000444	0.000507	CcSEcCtD
Tizanidine—Body temperature increased—Docetaxel—ovarian cancer	0.000444	0.000507	CcSEcCtD
Tizanidine—Arrhythmia—Doxorubicin—ovarian cancer	0.000441	0.000503	CcSEcCtD
Tizanidine—Dizziness—Paclitaxel—ovarian cancer	0.000438	0.0005	CcSEcCtD
Tizanidine—Vision blurred—Epirubicin—ovarian cancer	0.000437	0.000499	CcSEcCtD
Tizanidine—Alopecia—Doxorubicin—ovarian cancer	0.000436	0.000498	CcSEcCtD
Tizanidine—Mental disorder—Doxorubicin—ovarian cancer	0.000432	0.000493	CcSEcCtD
Tizanidine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000431	0.000492	CcSEcCtD
Tizanidine—Anaemia—Epirubicin—ovarian cancer	0.000429	0.00049	CcSEcCtD
Tizanidine—Agitation—Epirubicin—ovarian cancer	0.000426	0.000487	CcSEcCtD
Tizanidine—Flatulence—Doxorubicin—ovarian cancer	0.000423	0.000483	CcSEcCtD
Tizanidine—Tension—Doxorubicin—ovarian cancer	0.000421	0.000481	CcSEcCtD
Tizanidine—Vomiting—Paclitaxel—ovarian cancer	0.000421	0.000481	CcSEcCtD
Tizanidine—Malaise—Epirubicin—ovarian cancer	0.000418	0.000478	CcSEcCtD
Tizanidine—Rash—Paclitaxel—ovarian cancer	0.000418	0.000477	CcSEcCtD
Tizanidine—Dermatitis—Paclitaxel—ovarian cancer	0.000417	0.000476	CcSEcCtD
Tizanidine—Nervousness—Doxorubicin—ovarian cancer	0.000417	0.000476	CcSEcCtD
Tizanidine—Vertigo—Epirubicin—ovarian cancer	0.000417	0.000476	CcSEcCtD
Tizanidine—Syncope—Epirubicin—ovarian cancer	0.000416	0.000475	CcSEcCtD
Tizanidine—Leukopenia—Epirubicin—ovarian cancer	0.000415	0.000474	CcSEcCtD
Tizanidine—Back pain—Doxorubicin—ovarian cancer	0.000415	0.000474	CcSEcCtD
Tizanidine—Hypersensitivity—Docetaxel—ovarian cancer	0.000414	0.000472	CcSEcCtD
Tizanidine—Muscle spasms—Doxorubicin—ovarian cancer	0.000413	0.000471	CcSEcCtD
Tizanidine—Loss of consciousness—Epirubicin—ovarian cancer	0.000408	0.000466	CcSEcCtD
Tizanidine—Vision blurred—Doxorubicin—ovarian cancer	0.000405	0.000462	CcSEcCtD
Tizanidine—Asthenia—Docetaxel—ovarian cancer	0.000403	0.00046	CcSEcCtD
Tizanidine—Convulsion—Epirubicin—ovarian cancer	0.000402	0.000459	CcSEcCtD
Tizanidine—Hypertension—Epirubicin—ovarian cancer	0.000401	0.000457	CcSEcCtD
Tizanidine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000398	0.000455	CcSEcCtD
Tizanidine—Pruritus—Docetaxel—ovarian cancer	0.000397	0.000454	CcSEcCtD
Tizanidine—Anaemia—Doxorubicin—ovarian cancer	0.000397	0.000453	CcSEcCtD
Tizanidine—Arthralgia—Epirubicin—ovarian cancer	0.000395	0.000451	CcSEcCtD
Tizanidine—Agitation—Doxorubicin—ovarian cancer	0.000395	0.00045	CcSEcCtD
Tizanidine—Anxiety—Epirubicin—ovarian cancer	0.000394	0.000449	CcSEcCtD
Tizanidine—Nausea—Paclitaxel—ovarian cancer	0.000393	0.000449	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000392	0.000448	CcSEcCtD
Tizanidine—Discomfort—Epirubicin—ovarian cancer	0.00039	0.000446	CcSEcCtD
Tizanidine—Malaise—Doxorubicin—ovarian cancer	0.000387	0.000442	CcSEcCtD
Tizanidine—Dry mouth—Epirubicin—ovarian cancer	0.000386	0.000441	CcSEcCtD
Tizanidine—Vertigo—Doxorubicin—ovarian cancer	0.000386	0.00044	CcSEcCtD
Tizanidine—Syncope—Doxorubicin—ovarian cancer	0.000385	0.00044	CcSEcCtD
Tizanidine—Leukopenia—Doxorubicin—ovarian cancer	0.000384	0.000439	CcSEcCtD
Tizanidine—Diarrhoea—Docetaxel—ovarian cancer	0.000384	0.000439	CcSEcCtD
Tizanidine—Confusional state—Epirubicin—ovarian cancer	0.000382	0.000436	CcSEcCtD
Tizanidine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000379	0.000432	CcSEcCtD
Tizanidine—Oedema—Epirubicin—ovarian cancer	0.000379	0.000432	CcSEcCtD
Tizanidine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000377	0.000431	CcSEcCtD
Tizanidine—Infection—Epirubicin—ovarian cancer	0.000376	0.00043	CcSEcCtD
Tizanidine—Shock—Epirubicin—ovarian cancer	0.000373	0.000425	CcSEcCtD
Tizanidine—Convulsion—Doxorubicin—ovarian cancer	0.000372	0.000425	CcSEcCtD
Tizanidine—Nervous system disorder—Epirubicin—ovarian cancer	0.000371	0.000424	CcSEcCtD
Tizanidine—Dizziness—Docetaxel—ovarian cancer	0.000371	0.000424	CcSEcCtD
Tizanidine—Thrombocytopenia—Epirubicin—ovarian cancer	0.000371	0.000423	CcSEcCtD
Tizanidine—Hypertension—Doxorubicin—ovarian cancer	0.000371	0.000423	CcSEcCtD
Tizanidine—Tachycardia—Epirubicin—ovarian cancer	0.00037	0.000422	CcSEcCtD
Tizanidine—Skin disorder—Epirubicin—ovarian cancer	0.000368	0.00042	CcSEcCtD
Tizanidine—Hyperhidrosis—Epirubicin—ovarian cancer	0.000366	0.000418	CcSEcCtD
Tizanidine—Arthralgia—Doxorubicin—ovarian cancer	0.000366	0.000417	CcSEcCtD
Tizanidine—Anxiety—Doxorubicin—ovarian cancer	0.000364	0.000416	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000363	0.000414	CcSEcCtD
Tizanidine—Discomfort—Doxorubicin—ovarian cancer	0.000361	0.000412	CcSEcCtD
Tizanidine—Dry mouth—Doxorubicin—ovarian cancer	0.000357	0.000408	CcSEcCtD
Tizanidine—Vomiting—Docetaxel—ovarian cancer	0.000357	0.000408	CcSEcCtD
Tizanidine—Rash—Docetaxel—ovarian cancer	0.000354	0.000404	CcSEcCtD
Tizanidine—Hypotension—Epirubicin—ovarian cancer	0.000354	0.000404	CcSEcCtD
Tizanidine—Dermatitis—Docetaxel—ovarian cancer	0.000354	0.000404	CcSEcCtD
Tizanidine—Confusional state—Doxorubicin—ovarian cancer	0.000353	0.000403	CcSEcCtD
Tizanidine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00035	0.0004	CcSEcCtD
Tizanidine—Oedema—Doxorubicin—ovarian cancer	0.00035	0.0004	CcSEcCtD
Tizanidine—Infection—Doxorubicin—ovarian cancer	0.000348	0.000397	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000345	0.000394	CcSEcCtD
Tizanidine—Shock—Doxorubicin—ovarian cancer	0.000345	0.000394	CcSEcCtD
Tizanidine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000344	0.000392	CcSEcCtD
Tizanidine—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000343	0.000392	CcSEcCtD
Tizanidine—Tachycardia—Doxorubicin—ovarian cancer	0.000342	0.00039	CcSEcCtD
Tizanidine—Skin disorder—Doxorubicin—ovarian cancer	0.00034	0.000389	CcSEcCtD
Tizanidine—Paraesthesia—Epirubicin—ovarian cancer	0.00034	0.000388	CcSEcCtD
Tizanidine—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000339	0.000387	CcSEcCtD
Tizanidine—Dyspnoea—Epirubicin—ovarian cancer	0.000338	0.000385	CcSEcCtD
Tizanidine—Somnolence—Epirubicin—ovarian cancer	0.000337	0.000384	CcSEcCtD
Tizanidine—Nausea—Docetaxel—ovarian cancer	0.000334	0.000381	CcSEcCtD
Tizanidine—Dyspepsia—Epirubicin—ovarian cancer	0.000333	0.000381	CcSEcCtD
Tizanidine—Hypotension—Doxorubicin—ovarian cancer	0.000327	0.000374	CcSEcCtD
Tizanidine—Fatigue—Epirubicin—ovarian cancer	0.000327	0.000373	CcSEcCtD
Tizanidine—Constipation—Epirubicin—ovarian cancer	0.000324	0.00037	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000319	0.000364	CcSEcCtD
Tizanidine—Paraesthesia—Doxorubicin—ovarian cancer	0.000315	0.000359	CcSEcCtD
Tizanidine—Dyspnoea—Doxorubicin—ovarian cancer	0.000312	0.000357	CcSEcCtD
Tizanidine—Feeling abnormal—Epirubicin—ovarian cancer	0.000312	0.000356	CcSEcCtD
Tizanidine—Somnolence—Doxorubicin—ovarian cancer	0.000312	0.000356	CcSEcCtD
Tizanidine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00031	0.000354	CcSEcCtD
Tizanidine—Dyspepsia—Doxorubicin—ovarian cancer	0.000308	0.000352	CcSEcCtD
Tizanidine—Fatigue—Doxorubicin—ovarian cancer	0.000302	0.000345	CcSEcCtD
Tizanidine—Urticaria—Epirubicin—ovarian cancer	0.000301	0.000343	CcSEcCtD
Tizanidine—Constipation—Doxorubicin—ovarian cancer	0.0003	0.000342	CcSEcCtD
Tizanidine—Abdominal pain—Epirubicin—ovarian cancer	0.000299	0.000342	CcSEcCtD
Tizanidine—Body temperature increased—Epirubicin—ovarian cancer	0.000299	0.000342	CcSEcCtD
Tizanidine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000289	0.00033	CcSEcCtD
Tizanidine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000287	0.000327	CcSEcCtD
Tizanidine—Hypersensitivity—Epirubicin—ovarian cancer	0.000279	0.000319	CcSEcCtD
Tizanidine—Urticaria—Doxorubicin—ovarian cancer	0.000278	0.000318	CcSEcCtD
Tizanidine—Abdominal pain—Doxorubicin—ovarian cancer	0.000277	0.000316	CcSEcCtD
Tizanidine—Body temperature increased—Doxorubicin—ovarian cancer	0.000277	0.000316	CcSEcCtD
Tizanidine—Asthenia—Epirubicin—ovarian cancer	0.000272	0.00031	CcSEcCtD
Tizanidine—Pruritus—Epirubicin—ovarian cancer	0.000268	0.000306	CcSEcCtD
Tizanidine—Diarrhoea—Epirubicin—ovarian cancer	0.000259	0.000296	CcSEcCtD
Tizanidine—Hypersensitivity—Doxorubicin—ovarian cancer	0.000258	0.000295	CcSEcCtD
Tizanidine—Asthenia—Doxorubicin—ovarian cancer	0.000251	0.000287	CcSEcCtD
Tizanidine—Dizziness—Epirubicin—ovarian cancer	0.00025	0.000286	CcSEcCtD
Tizanidine—Pruritus—Doxorubicin—ovarian cancer	0.000248	0.000283	CcSEcCtD
Tizanidine—Vomiting—Epirubicin—ovarian cancer	0.000241	0.000275	CcSEcCtD
Tizanidine—Diarrhoea—Doxorubicin—ovarian cancer	0.00024	0.000274	CcSEcCtD
Tizanidine—Rash—Epirubicin—ovarian cancer	0.000239	0.000273	CcSEcCtD
Tizanidine—Dermatitis—Epirubicin—ovarian cancer	0.000239	0.000272	CcSEcCtD
Tizanidine—Dizziness—Doxorubicin—ovarian cancer	0.000232	0.000265	CcSEcCtD
Tizanidine—Nausea—Epirubicin—ovarian cancer	0.000225	0.000257	CcSEcCtD
Tizanidine—Vomiting—Doxorubicin—ovarian cancer	0.000223	0.000254	CcSEcCtD
Tizanidine—Rash—Doxorubicin—ovarian cancer	0.000221	0.000252	CcSEcCtD
Tizanidine—Dermatitis—Doxorubicin—ovarian cancer	0.000221	0.000252	CcSEcCtD
Tizanidine—Nausea—Doxorubicin—ovarian cancer	0.000208	0.000238	CcSEcCtD
